E
Astrotech Corporation ASTC
$2.37 -$0.05-2.15% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Astrotech Corporation is a U.S.-based technology company that operates at the intersection of aerospace services, defense and security technologies, and analytical instrumentation. The company focuses on providing specialized payload processing and launch support services for space missions, as well as developing advanced mass spectrometry–based detection systems for security, defense, and healthcare applications. Its primary revenue drivers historically have included spaceflight-related services and the commercialization of proprietary detection technologies through its subsidiaries.

Founded in 1984, the company has evolved from a space infrastructure and services provider supporting government and commercial launch activities into a diversified technology holding company. Astrotech’s strategy has emphasized leveraging intellectual property developed for aerospace applications into adjacent markets such as explosives detection, chemical analysis, and non-invasive medical diagnostics. The company is publicly traded on Nasdaq under the ticker ASTC.

Business Operations

Astrotech conducts its operations through distinct business units and subsidiaries, with activities primarily organized around Aerospace Technology and Detection and Analytical Instrumentation. Through Astrotech Space Operations, Inc., the company provides payload processing, fueling, and integration services for satellites and spaceflight hardware, supporting government agencies, defense contractors, and commercial space companies. These services are closely tied to U.S. launch infrastructure and are project-based in nature.

In the analytical technology segment, Astrotech operates through subsidiaries including 1st Detect Corporation and BreathTech Corporation. 1st Detect Corporation focuses on trace explosives and narcotics detection systems using mass spectrometry for defense, homeland security, and transportation markets. BreathTech Corporation is engaged in the development of breath analysis technologies aimed at non-invasive disease detection and health monitoring. Revenue generation in these segments is driven by product development milestones, government contracts, and early-stage commercialization efforts.

Strategic Position & Investments

Astrotech’s strategic direction centers on monetizing proprietary mass spectrometry technology across multiple high-value markets while maintaining a niche but established role in U.S. space launch operations. Growth initiatives have included continued investment in detection technologies that address defense, security, and healthcare needs, with an emphasis on miniaturization, sensitivity, and real-time analysis capabilities.

The company has historically allocated capital toward its wholly owned subsidiaries rather than large-scale external acquisitions. 1st Detect Corporation and BreathTech Corporation represent the core of Astrotech’s technology investment strategy, each targeting different end markets using a shared technological foundation. The company’s investments reflect a long-term approach, with commercialization timelines influenced by regulatory requirements, customer validation, and government procurement cycles.

Geographic Footprint

Astrotech Corporation is headquartered in Titusville, Florida, and its operations are primarily concentrated in the United States. Its aerospace services activities are closely associated with launch operations at and around Kennedy Space Center and other U.S. space infrastructure facilities, positioning the company within a critical geographic hub for national and commercial spaceflight.

While the company does not maintain a broad international operational footprint, its technologies are designed for global applicability. Detection and analytical products developed by Astrotech’s subsidiaries are intended for potential deployment in North America, Europe, and other international markets, particularly where defense, transportation security, or healthcare diagnostics demand advanced detection solutions.

Leadership & Governance

Astrotech is led by an executive team with long-standing involvement in the company’s strategic development and technology focus. Leadership emphasizes disciplined capital allocation, protection and commercialization of intellectual property, and alignment with government and institutional customers in regulated markets.

Key executives include:

  • Thomas B. Pickens III � Chairman, Chief Executive Officer, and Chief Technology Officer
  • Kristina PickensChief Financial Officer
  • G. Scott RobinsonChief Operating Officer

The leadership team’s strategic vision centers on building long-term value through technology differentiation, particularly in mass spectrometry applications, while sustaining Astrotech’s legacy role in U.S. aerospace operations.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $180.40
B
AAPL NASDAQ $249.94
B
MSFT NASDAQ $391.79
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $121.98
B
Top Financial Stocks
See All »
B
B
JPM NYSE $287.74
B
V NYSE $299.02
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.24
Top Health Care Stocks
See All »
B
LLY NYSE $918.05
B
JNJ NYSE $237.28
B
AMGN NASDAQ $351.48
Top Real Estate Stocks
See All »
B
PLD NYSE $131.20